← Product Code [HSB](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB) · K051624 # T2 RECON NAIL SYSTEM (K051624) _Howmedica Osteonics Corp. · HSB · Jul 7, 2005 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K051624 ## Device Facts - **Applicant:** Howmedica Osteonics Corp. - **Product Code:** [HSB](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB.md) - **Decision Date:** Jul 7, 2005 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 888.3020 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Intended Use The subject T2 Recon Nail System is a fracture fixation device comprised of Femoral Nails, Locking Screws, Set Screws, End Caps, and Lag Screws. The subject and predicate devices are intended to provide strong and stable internal fracture fixation while minimizing soft tissue irritation. This device is utilized as an aid to healing, not as a substitute for normal intact bone and tissue. The T2 Recon Nail indications include fixation of subtrochanteric, interochanteric, ipsilateral neck/shaft, communited proximal femoral shaft fractures, femoral fixation required as a result of pathological disease, and temporary stabilization of fractures of the femoral shaft ranging from the femoral neck to the supracondylar regions of the femur. ## Device Story The T2 Recon Nail System is an intramedullary (IM) nail device used for femoral fracture fixation. It consists of femoral nails, locking screws, set screws, end caps, and lag screws. The device is implanted by a surgeon in an operating room to provide internal stabilization of bone fractures, acting as an aid to healing. It is not intended to replace normal bone or tissue. The system is a line extension of the existing T2 Recon Nail System, utilizing similar materials and mechanical properties to achieve fracture stability. ## Clinical Evidence Bench testing only. ## Technological Characteristics The device is constructed from titanium alloy and PEEK. It functions as an intramedullary fixation rod. No software or electronic components are involved. ## Regulatory Identification An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ T2® Recon Line Extension K051624 # 510(k) Summary of Safety and Effectiveness: T2® Recon Nail System Line Extension JUL 7 - 2005 | Submission Information | | |--------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Name and Address of the Sponsor
of the 510(k) Submission: | Howmedica Osteonics Corp
325 Corporate Drive
Mahwah, NJ 07430 | | For Information contact: | Vivian Kelly, Regulatory Affairs Specialist
Howmedica Osteonics Corp.
325 Corporate Drive
Mahwah, NJ 07430
Phone: (201) 831-5581
Fax: (201) 831-6038 | | Date Summary Prepared: | June 17, 2005 | | Device Identification | | | Proprietary Name: | T2® Recon Nail System | | Common Name: | Intramedullary Nail | | Classification Name and Reference: | Intramedullary Fixation Rod and Accessories
21 CFR §888.3020 | | Device Product Code: | 87 HSB | #### Description: Description. The T2® Recon Nail System is a family of IM Nails for various types of femoral fractures. This The 12 Tecon Fran Bystein is a line extension to the T2® Recon Nail System to add an alternate Special 210(x) submission is a there is no change in intended use for the subject device, which is provided below. ### Intended Use: The subject T2 " Recon Nail System is a fracture fixation device comprised of Femoral Nails and 1116 subject 1 = 1 coon Prashers, Locking Screws, Set Screws, End Caps, and Lag Screws. the subject and predicate devices are intended to provide strong and stable internal fracture The subjour and product tissue irritation. This device is utilized as an aid to healing, not as a substitute for normal intact bone and tissue. The T2® Recon Nail indications include fixation of subtrochanteric, interochanteric, ipsilateral neck/shaft, communited proximal femoral shaft fractures, femoral fixation required as a result of necks shart, communitied promotary stabilization of fractures of the femoral shaft ranging from the femoral neck to the supracondylar regions of the femur. ## Statement of Technological Comparison: Statement of Technological Obligation alloy and PEEK while the predicate device is made The subject as rios is normanical testing demonstrates the comparable mechanical properties of the subject T2® Recon Nail System to the predicate device. {1}------------------------------------------------ # DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 JUL 7 - 2005 Ms. Vivian Kelley, RAC Regulatory Affairs Specialist Howmedica Osteonics Corporation 325 Corporate Drive Mahwah, New Jersey USA 07430 Re: K051624 Trade/Device Name: T2® Recon Nail System Regulation Number: 21 CFR 888.3020 Regulation Name: Intramedullary fixation rod Regulatory Class: II Product Code: HSB Dated: June 17, 2005 Received: June 20, 2005 Dear Ms. Kelley: We have reviewed your Section 510(k) premarket notification of intent to market the device we nave reviewed your because is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate 101 use stated in the encreate) to regary the enactment date of the Medical Device Amendments, or to commerce pror to May 20, 1978, in accordance with the provisions of the Federal Food, Drug, devices mat have been recuire approval of a premarket approval application (PMA). and Cosmetic Act (71ct) that ao novice, subject to the general controls provisions of the Act. The Tou may, merelore, market the act include requirements for annual registration, listing of general controll provision practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it your device is elassified (600 acal controls. Existing major regulations affecting your device It may be sugled to Sach addiness Regulations, Title 21, Parts 800 to 898. In addition, FDA can oc found in the overants concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean F least of advised that I DTC issualite of your device complies with other requirements of the Act that I DT has intace and regulations administered by other Federal agencies. You must of any I catelli stututes and registments, including, but not limited to: registration and listing (21 Comply with an the Net 8 requirements) and manufacturing practice requirements as set CI I rull 6077, idoomig (21 cegulation (21 CFR Part 820); and if applicable, the electronic forth in the quality by over of ovisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ Page 2 - Ms. Vivian Kelley, RAC This letter will allow you to begin marketing your device as described in your Section 5 10(k) I his letter will anow you to begin manxemig your antial equivalence of your device to a legally premarket notification. The FDA finding of substantial equivale website premarket notification. "The PDT Intamge of cassement of the spermits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific advice for your ace at (240) 276-0120 . Also, please note the regulation entitled, comaci the Office of Comphalled at (210) 276 or art 807.97). You may obtain "Misbranding by relefence to premarket noulification of Set from the Division of Small other general information on your responsibilities under the Act from work on 6800 638, other general Informational and Consumer Assistance at its toll-free number (800) 638-2041 or and index html Manufacturers, International and Consulter Pibelows of the many of the many in the samm Sincerely yours, Stupt hurla Miriam C. Provost, Ph.D. Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ # Indications for Use 510(k) Number (if known): K Device Name: T2® Recon Nail System Indications For Use: The T2® Recon Nail indications include fixation of subtrochanteric, interochanteric, ipsilateral neck/shaft, communited proximal femoral shaft fractures, femoral fixation required as a result of pathological disease, and temporary stabilization of fractures of the femoral shaft ranging from the femoral neck to the supracondylar regions of the femur. Prescription Use _____________________________________________________________________________________________________________________________________________________________ AND/OR Over-The-Counter Use _ (21 CFR 807 Subpart C) (Part 21 CFR 801 Subpart D) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) # Concurrence of CDRH, Office of Device Evaluation (ODE) Page 1 of 1 Stypt Clurke Division of General, Restorative, and Neurological Devices 510(k) Number_________________________________________________________________________________________________________________________________________________________________ --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K051624](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HSB/K051624) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com